Literature DB >> 26970656

Biological Motion induced mu suppression is reduced in Early Psychosis (EP) patients with active negative symptoms and Autism Spectrum Disorders (ASD).

Amedeo Minichino1, Fiza Singh2, Jaime Pineda3, Elisabeth Friederich3, Kristin S Cadenhead2.   

Abstract

There is evidence of genetic and neural system overlap in Autism Spectrum Disorder (ASD) and Early Psychosis (EP). Five datasets were pooled to compare mu suppression index (MSI), a proxy of mirror neuron activity, in EP, high functioning ASD, and healthy subjects (HS). ASDs and EPs with "active" negative symptoms showed significant differences in mu suppression, in response to Biological Motion/point-light display animation, compared to HS. Preliminary findings suggest that similar neural network deficits in ASD and EP could be driven by the expression of negative symptoms in the latter group of patients. These findings may aid future studies on EP and ASD and facilitate the formulation of new hypotheses regarding their pathophysiology.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Biological Motion; Early Psychosis; Mirror neurons; Negative symptoms; Posterior superior temporal sulcus

Mesh:

Year:  2016        PMID: 26970656     DOI: 10.1016/j.psychres.2016.01.057

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  3 in total

1.  Mirror Neurons in Psychiatric Disorders: from Neuroception to Bio-behavioral System Dysregulation.

Authors:  Amedeo Minichino; Kristin Cadenhead
Journal:  Neuropsychopharmacology       Date:  2017-01       Impact factor: 7.853

Review 2.  Autism spectrum disorder and schizophrenia: An updated conceptual review.

Authors:  Amandeep Jutla; Jennifer Foss-Feig; Jeremy Veenstra-VanderWeele
Journal:  Autism Res       Date:  2021-12-29       Impact factor: 5.216

3.  Measuring Brain Complexity During Neural Motor Resonance.

Authors:  Brandon M Hager; Albert C Yang; Jennifer N Gutsell
Journal:  Front Neurosci       Date:  2018-10-30       Impact factor: 4.677

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.